Radius Ventures is a venture capital company that invests in healthcare and life sciences companies.
Business Model:
Revenue: $15.6M
Employees: 2-10
Address: 400 Madison Ave
City: New York
State: NY
Zip: 10017
Country: US
Radius Ventures is a venture capital firm that invests in leading-edge, growth equity and expansion-stage health and life sciences companies. The firm is led by a seasoned group of investment professionals with collective experience across all major sectors of the industry, including medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services and healthcare information technology. Radius takes a hands-on approach with each portfolio company by providing intellectual capital, strategic guidance and access to key industry relationships that ultimately increase the odds of success. Founded in 1997, Radius Ventures is based in New York, United States.
Contact Phone:
+12128977778
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2007 | Targanta Therapeutics | Series C | 70M |
10/2012 | Tactile Medical | Series B | 10.4M |
1/2013 | Healthsense | Venture Round | 0 |
7/2005 | Eyetel Imaging | Series B | 17.7M |
10/2005 | Heartscape Technologies, Inc. | Venture Round | 1.4M |
5/2014 | EndoGastric Solutions | Series G | 0 |
11/2007 | Medingo Medical Solutions | Venture Round | 27M |
11/2002 | Health Language,Inc. | Series A | 0 |
5/2007 | Biostorage Technologies | Series A | 8.3M |
11/2012 | Ambit Biosciences | Venture Round | 0 |
9/2005 | Heartscape Technologies, Inc. | Venture Round | 1.6M |
8/2008 | Heartscape Technologies, Inc. | Venture Round | 3M |
6/2011 | Ambit Biosciences | Series D | 0 |
3/2012 | EndoGastric Solutions | Series G | 10.9M |
5/2014 | Impliant | Venture Round | 0 |
6/2013 | Minimally invasive devices | Series B | 0 |
6/2018 | EndoGastric Solutions | Series I | 0 |
11/2015 | Minimally invasive devices | Series C | 0 |
1/2004 | ZettaCore | Series B | 17.5M |
6/2000 | TheScientificWorld | Series A | 8M |
5/2000 | Amicas | Post-IPO Equity | 4.5M |
8/2014 | Healthsense | Venture Round | 0 |
1/2004 | Eyetel Imaging | Series B | 10.7M |
8/2010 | Healthsense | Series B | 6.8M |
12/2001 | NuGEN Technologies | Series B | 0 |
8/2003 | NuGEN Technologies | Series C | 0 |
12/2015 | EndoGastric Solutions | Venture Round | 0 |
6/2014 | Minimally invasive devices | Debt Financing | 0 |
6/2007 | U-Systems | Venture Round | 0 |
3/2004 | Phylogix Inc. | Series B | 12M |
4/2007 | Heartscape Technologies, Inc. | Series B | 17M |
11/2007 | Ambit Biosciences | Series D | 49.3M |
9/2005 | Amicus Therapeutics | Series C | 55M |
8/2010 | EndoGastric Solutions | Series F | 0 |
5/2004 | Amicus Therapeutics | Series B | 31M |
9/2006 | Amicus Therapeutics | Series D | 60M |
4/2010 | Management Health Solutions, Inc. | Series B | 0 |
2/2006 | Heartscape Technologies, Inc. | Series A | 3M |
6/2012 | EndoGastric Solutions | Venture Round | 0 |
4/2012 | EndoGastric Solutions | Venture Round | 0 |
6/2007 | Athersys | Venture Round | 0 |
1/2006 | Heartscape Technologies, Inc. | Venture Round | 3M |
5/2011 | U-Systems | Venture Round | 0 |
9/2013 | Tabula Rasa Healthcare (formerly CareKinesis) | Venture Round | 4M |
5/2002 | ZettaCore | Series A | 2.5M |
6/2018 | EndoGastric Solutions | Series I | 0 |
12/2015 | EndoGastric Solutions | Venture Round | 0 |
11/2015 | Minimally invasive devices | Series C | 0 |
8/2014 | Healthsense | Venture Round | 0 |
6/2014 | Minimally invasive devices | Debt Financing | 0 |
5/2014 | Impliant | Venture Round | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
9/2013 | Tabula Rasa Healthcare (formerly CareKinesis) | Venture Round | 0 |
6/2013 | Minimally invasive devices | Series B | 0 |
1/2013 | Healthsense | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|